Ms. Chaliya Wamaloon, Ph.D.
Deputy
Director of Nursing of Ubon Ratchathani Cancer Hospital, Thailand
Ms. Chaliya Wamaloon, Ph.D.
Deputy Director of Nursing of Ubon Ratchathani Cancer Hospital, ThailandSpeaker's Biography
Chaliya Wamaloon, RN, BSN, M.Ed., Ph.D., works as the Deputy Director of Nursing at Ubonratchathani Cancer Hospital in Thailand. She has eight years of experience in the operation room at Supasittiprasong Hospital and 27 years in the Nursing Department at Ubonratchathani Cancer Hospital. She has vast experience dealing with a comprehensive range of medical conditions, bringing forth the ability to thoroughly and accurately assess patients' health and prescribe the proper treatment program for optimal health moving forward. Dr. Chaliya is adept at working as a collaborative team member to ensure that patients receive the highest level of care possible.
Topic
Precision Medicine Implement in Oncology: Cancer
Genetic Risk Assessment and Counseling
Abstract
Although only five to ten percent of all cancer cases are attributable to a highly penetrant cancer predisposition gene, identifying individuals at inherited risk for cancer has become an integral part of the practice of predictive and preventative medicine. Identifying those individuals with a significantly higher risk of developing specific cancers allow healthcare providers to intervene with appropriate counseling and education, increased cancer surveillance, and sometimes even cancer prevention. This document aims to present the identification of patients at high risk for hereditary cancer in Ubon Ratchathani Cancer Hospital, Thailand, focusing on hereditary breast and ovarian cancer (HBOC) and the importance of referral to genetic counselors and other genetics professionals.
The process of cancer risk assessment and counseling followed NCCN guidelines version 2.2021 related to stages:
Pre-test counseling is done before ordering testing.
Consideration of the most appropriate tests to order.
Post-test counseling is done when results are disclosed.
The purpose of cancer genetic counseling is to educate individuals about the genetic and factors related to the individual's cancer diagnosis and/or risk for the disease to help them derive personal meaning from cancer genetic information, and to empower them to make educated, informed decisions about genetic testing, cancer screening, and cancer prevention.
In summary, counseling for hereditary breast and/or ovarian cancer uses a broad approach to place genetic risk in the context of other related risk factors, thereby customizing counseling to the experiences of the individual.